Bispecific Adapter-Mediated Retargeting of a Receptor-Restricted HSV-1 Vector to CEA-Bearing Tumor Cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Baek, Hyunjung | - |
dc.contributor.author | Uchida, Hiroaki | - |
dc.contributor.author | Jun, Kyungok | - |
dc.contributor.author | Kim, Jae-Hong | - |
dc.contributor.author | Kuroki, Masahide | - |
dc.contributor.author | Cohen, Justus B. | - |
dc.contributor.author | Glorioso, Joseph C. | - |
dc.contributor.author | Kwon, Heechung | - |
dc.date.accessioned | 2021-09-07T14:23:06Z | - |
dc.date.available | 2021-09-07T14:23:06Z | - |
dc.date.created | 2021-06-14 | - |
dc.date.issued | 2011-03 | - |
dc.identifier.issn | 1525-0016 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/112881 | - |
dc.description.abstract | The safety and efficacy of viral therapies for solid tumors can be enhanced by redirecting the virus infection to tumor-specific cell-surface markers. Successful retargeting of herpes simplex virus type 1 (HSV-1) has been achieved using vectors that carry a modified envelope glycoprotein D (gD) engineered to interact directly with novel receptors. In addition, soluble bridging molecules (adapters) have been used to link gD indirectly to cellspecific receptors. Here, we describe the development of an adapter connecting gD to the common tumor antigen carcinoembryonic antigen (CEA). The adapter consisted of a CEA-specific single-chain antibody fused to the gD-binding region of the gD receptor, herpes virus entry mediator (HVEM). We used this adapter in combination with a vector that is detargeted for recognition of the widely expressed gD receptor nectin-1, but retains an intact binding region for the less common HVEM. We show that the adapter enabled infection of HSV-resistant Chinese hamster ovary (CHO) cells expressing ectopic CEA and nectin-1/CEA-bearing human gastric carcinoma cells that are resistant to the vector alone. We observed cell-to-cell spread following adapter-mediated infection in vitro and reduced tumor growth in vivo, indicating that this method of vector retargeting may provide a novel strategy for tumor-specific delivery of tumoricidal HSV. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | CELL PRESS | - |
dc.subject | HERPES-SIMPLEX-VIRUS | - |
dc.subject | GROWTH-FACTOR RECEPTOR | - |
dc.subject | GLYCOPROTEIN-D | - |
dc.subject | CARCINOEMBRYONIC ANTIGEN | - |
dc.subject | ENTRY MEDIATOR | - |
dc.subject | GENE-THERAPY | - |
dc.subject | REPLICATING ADENOVIRUS | - |
dc.subject | TARGETED BINDING | - |
dc.subject | POSITIVE CELLS | - |
dc.subject | TYPE-1 | - |
dc.title | Bispecific Adapter-Mediated Retargeting of a Receptor-Restricted HSV-1 Vector to CEA-Bearing Tumor Cells | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Jae-Hong | - |
dc.identifier.doi | 10.1038/mt.2010.207 | - |
dc.identifier.scopusid | 2-s2.0-79952190298 | - |
dc.identifier.wosid | 000287911600010 | - |
dc.identifier.bibliographicCitation | MOLECULAR THERAPY, v.19, no.3, pp.507 - 514 | - |
dc.relation.isPartOf | MOLECULAR THERAPY | - |
dc.citation.title | MOLECULAR THERAPY | - |
dc.citation.volume | 19 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 507 | - |
dc.citation.endPage | 514 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biotechnology & Applied Microbiology | - |
dc.relation.journalResearchArea | Genetics & Heredity | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Biotechnology & Applied Microbiology | - |
dc.relation.journalWebOfScienceCategory | Genetics & Heredity | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.subject.keywordPlus | HERPES-SIMPLEX-VIRUS | - |
dc.subject.keywordPlus | GROWTH-FACTOR RECEPTOR | - |
dc.subject.keywordPlus | GLYCOPROTEIN-D | - |
dc.subject.keywordPlus | CARCINOEMBRYONIC ANTIGEN | - |
dc.subject.keywordPlus | ENTRY MEDIATOR | - |
dc.subject.keywordPlus | GENE-THERAPY | - |
dc.subject.keywordPlus | REPLICATING ADENOVIRUS | - |
dc.subject.keywordPlus | TARGETED BINDING | - |
dc.subject.keywordPlus | POSITIVE CELLS | - |
dc.subject.keywordPlus | TYPE-1 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.